Announcements & Media Coverage

Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”)   Presentation at H.C. Wainwright Global Investment Conference   Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce its participation in the H.C. Wainwright 24th Annual Global Investment Conference to be held on September 12-14, 2022,...